Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Adli M, Bschor T, Canata B, Dopfmer S, Bauer M. [Lithium in the treatment of acute depression]. Fortschr Neurol Psychiatr. 1998;66:435–41.
Akiskal HS, Mallya G. Criteria for the “soft” bipolar spectrum: treatment implications. Psychopharmacol Bull. 1987;23:68–73.
Akiskal HS, Djenderedjian AM, Rosenthal RH, Khani MK. Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group. Am J Psychiatry. 1977;134:1227–33.
Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry. 1995;152:1130–8.
AMDP System. Association of Methodology and Documentation in Psychiatry: Manual for the Assessment and Documentation of Psychopathology. Berlin: Springer; 1982.
Angst J. Switch from depression to mania — a record study over decades between 1920 and 1982. Psychopathology. 1985,18:140–54.
Ballenger JC, Post RM. Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry. 1980;137:782–90.
Baumhackl U, Biziere K, Fischbach R et al. Efficacy and tolerability of moclobemide compared with imipramine in depressive disorder (DSM-III): an Austrian double-blind, multicentre study. Br J Psychiatry. 1989;155(Suppl. 6):78–83.
Boerlin HL, Gitlin MJ, Zoellner LA, Hammen CL. Bipolar depression and antidepressant-induced mania: a naturalistic study. J Clin Psychiatry. 1988;59:374–9.
Bottlender R, Rudolf D, Strauss A, Moller HJ. Antidepressant-associated maniform states in acute treatment of patients with bipolar-I depression. Eur Arch Psychiatry Clin Neurosci. 1998;248:296–300.
Bottlender R, Rudolf D, Strauss A, Möller HJ. Are low basal serum levels of the thyroid stimulating hormone (b-TSH) a risk factor for switches into states of expansive syndromes (known in Germany as “Maniform syndromes”) in bipolar I depression? Pharmacopsychiatry. 2000;33:75–7.
Bunney WE Jr. Psychopharmacology of the switch process in affective illness. In: Lipton MA, Kellam KF, editors. Psychopharmacology: a Generation of Progress. New York: Raven Press; 1978:1249–59.
Calabrese JR, Delucchi GA. Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder. Am J Psychiatry. 1990;147:431–4.
Calabrese JR, Woyshville MJ. A medication algorithm for treatment of bipolar rapid cycling? J Clin Psychiatry. 1995;56(Suppl. 3):11–18.
Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry. 1999;60:79–88.
Cohn JB, Collins G, Ashbrook E, Wernicke JF. A comparison of fluoxetine, imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol. 1989;4:313–22.
Coryell W, Endicott J, Keller M. Rapidly cycling affective disorder. Demographics, diagnosis, family history, and course. Arch Gen Psychiatry. 1992;49:126–31.
Dilsaver SC, Swarm SC, Chen YW et al. Treatment of bipolar depression with carbamazepine: results of an open study. Biol Psychiatry. 1996;40:935–7.
Fieve RR, Platman SR, Plutchik RR. The use of lithium in affective disorders. I. Acute endogenous depression. Am J Psychiatry. 1968;125:487–91.
Fogelson DL, Bystritsky A, Pasnau R. Bupropion in the treatment of bipolar disorders: the same old story? J Clin Psychiatry. 1992;53:443–6.
Frances AJ, Docherty JP, Kahn DA. The Expert Consensus Guidelines for treating depression in bipolar disorder. J Clin Psychiatry. 1996;57(Suppl. 12A):3–88.
Frances AJ, Kahn DA, Carpenter D, Docherty JP, Donovan SL. The Expert Consensus Guidelines for treating depression in bipolar disorder. J Clin Psychiatry. 1998;59(Suppl. 4):73–9.
Ghaemi SN, Lee-Cherry ER, Katzow JJ, Goodwin FK. Olanzapine treatment in mood disorders. APA Annual Meeting Abstracts 151: NR 136. 1998.
Goodwin GM, Nolen WA. Treatment of bipolar depressive mood disorders: algorithms for pharmacotherapy. Int J Psychiatry Clin Prac. 1997;l(Suppl. 1):S9–12.
Grunze H, Schlösser S, Walden J. Neue Perspektiven in der Akutbehandlung bipolarer Depressionen. Psychopharmakotherapie. 1999;6:53–9.
Himmelhoch JM, Thase ME, Mallinger AG, Houck P. Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry. 1991;148:910–16.
Hirschfeld RMA, Clayton PJ, Cohen I et al. Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association. Am J Psychiatry. 1994;151(Suppl.):l-36.
Hlastala SA, Frank E, Mallinger AG, Thase ME, Ritenour AM, Kupfer DJ. Bipolar depression: an underestimated treatment challenge. Depress Anxiety. 1997; 5:73–83.
Katz MM, Koslow SH, Maas JW et al. The timing, specificity and clinical prediction of tricyclic drug effects in depression. Psychol Med. 1987;17:297–309.
Khan MC, Wickham EA, Reed JV. Lithium versus placebo in acute depression: a clinical trial. Int Clin Psychopharmacol. 1987;2:47–54.
Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr Neuropsychopharmakol. 1980;13:156–67.
Kusumakar V, Yatham LN, Haslam DR et al. Treatment of mania, mixed state, and rapid cycling. Can J Psychiatry. 1997;42(Suppl. 2):79–86S.
Laakman G, Blaschke D, Hippius H, Messerer D. Alprazolam versus amitriptyline in the treatment of depressed out-patients: a randomized double-blind trial. In: Lader HL, Davies HC, editors. Drug Treatment of Neurotic Disorders. Edinburgh: Churchill Livingstone; 1986:129–36.
Laakman G, Faltermaier TM, Bossert ZS, Baghai T, Lorkowski G. Treatment of depressive outpatients with lorazepam, alprazolam, amytriptyline and placebo. Psychopharmacology Berl. 1995;120:109–15.
Lambert PA. Acute and prophylactic therapies of patients with affective disorders using valpromide (dipropylacetamide). In: Emrich HE, Okuma T, Müller AA, editors. Anticonvulsants in Affective Disorders. Amsterdam: Elsevier; 1984:33–44.
Lewis JL, Winokur G. The induction of mania. A natural history study with controls. Arch Gen Psychiatry. 1982;39:303–6.
Mendels J. Lithium in the treatment of depression. Am J Psychiatry. 1976;133:373–8.
Möller HJ. Klinische Prüfstudien. In: Riederer P, Laux G, Pöldinger W, editors. Allgemeine Grundlagen der Pharmakopsychiatrie. Wien: Springer; 1992:177–99.
Möller HJ, Riehl T, Dietzfelbinger T, Wernicke T. A controlled study of the efficacy and safety of mianserin and maprotiline in outpatients with major depression. Int Clin Psychopharmacol. 1991;6:179–92.
Möller HJ, Bottlender R, Grunze H, Strauss A, Wittmann J. Are antidepressants not or less effective in the acute treatment of bipolar I compared to unipolar depression? J Affect Disord. 2000 (in press).
Montgomery SA, Lecrubier Y. Is severe depression a separate indication? ECNP Consensus Meeting, 20 September 1996, Amsterdam. European College of Neuropsychopharmacology. Eur Neuropsychopharmacol. 1999;9:259–64.
Nemeroff CB. Treating depression in the bipolar patient. APA Annual Meeeting Abstracts. 1997;150:272.
Peet M. Induction of mania with selective serotonin re-uptake inhibitors and tricyclic antidepressants. Br J Psychiatry. 1994;164:549–50.
Pietzcker A, Gebhardt R, Strauss A, Stöckel M, Langer C, Freudenthal K. The syndrome scales in the AMDP system. In: Bobon D, Baumann U, Angst J, Helmchen H, Hippius H, editors. AMDP System in Pharmacopsychiatry. Basel: Karger; 1983:88–99.
Post RM, Uhde TW, Roy BP, Joffe RT. Antidepressant effects of carbamazepine. Am J Psychiatry. 1986;143:29–34.
Post RM, Leverich GS, Denicoff KD, Frye MA, Kimbrell TA, Dunn R. Alternative approaches to refractory depression in bipolar illness. Depress Anxiety. 1997;5:175–89.
Prien RF, Kupfer DJ, Mansky PA et al. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination. Arch Gen Psychiatry. 1984;41:1096–104.
Quitkin FM, Kane J, Rifkin A, Ramos LJ, Nayak DV. Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study. Arch Gen Psychiatry. 1981;38:902–7.
Reginaldi D, Tondo L, Caliari B, Minnai GP, Kukopulos A. The role of antidepressants in rapid cyclicity. Adv Biochem Psychopharmacol. 1982;32:363–7.
Rouillon F, Lejoyeaux M, Filteau MJ. Unwanted effects of long-term treatment. In: Montgomery SA, Rouillon FA, editors. Long-term Treatment of Depression. New York: Wiley; 1992:81–111.
Sachs GS. Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J Clin Psychopharmacol. 1996;16:32–47S.
Sachs GS, Lafer B, Stoll AL et al. A double-blind trial of bupropion versus desipramine for bipolar depression. J Clin Psychiatry. 1994;55:391–3.
Soares JC, Mann JJ. The anatomy of mood disorders — review of structural neuroimaging studies. Biol Psychiatry. 1997;41:86–106.
Souery D, Papadimitriou GN, Mendlewicz J. New molecular genetic studies in affective disorders. In: Papamitrou GN, Mendelwicz J, editors. Genetics of Mental Disorders, Part II: Clinical Issues. Bailliere’s Clinical Psychiatry, Vol. 2, No. 1. International practice and research. London: Baillière Tindall; 1996:1–13.
Souza FG, Goodwin GM. Lithium treatment and prophylaxis in unipolar depression: a meta-analysis. Br J Psychiatry. 1991;158:666–75.
Svestka J, Deskova E, Rysanek R, Nahunek K. Antiepileptics in the treatment of endogenous depression. Proceedings, IVth World Congress of Biological Psychiatry; 1991.
Tondo L, Laddomada P, Serra G, Minnai G, Kukopulos A. Rapid cyclers and antidepressants. Int Pharmacopsychiatry. 1981;16:119–23.
Walden J, Grunze H, Schlösser S et al. Empfehlungen für die Behandlung bipolarer affektiver Störungen [Recommendations for the treatment of bipolar affective disorder]. Psychopharmakotherapie. 1999;6:115–23.
Wehr TA, Goodwin FK. Rapid cycling between mania and depression caused by maintenance tricyclics. Psychopharmacol Bull. 1979a;15:17–19.
Wehr TA, Goodwin FK. Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry. 1979b;36:555–9.
Wehr TA, Sack DA, Rosenthal NE, Cowdry RW. Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients. Am J Psychiatry. 1988;145:179–84.
Yatham LN, Kusumakar V, Parikh SV et al. Bipolar depression: treatment options. Can J Psychiatry. 1997;42(Suppl. 2):87–91S.
Zornberg GL, Pope HG Jr. Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol. 1993;13:397–408.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Kluwer Academic Publishers
About this chapter
Cite this chapter
Möller, HJ., Grunze, H. (2000). Antidepressant treatment of bipolar depression. In: Marneros, A., Angst, J. (eds) Bipolar Disorders. Springer, Dordrecht. https://doi.org/10.1007/0-306-47521-9_19
Download citation
DOI: https://doi.org/10.1007/0-306-47521-9_19
Publisher Name: Springer, Dordrecht
Print ISBN: 978-0-7923-6588-4
Online ISBN: 978-0-306-47521-4
eBook Packages: Springer Book Archive